Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!
LAO Guo-qin, TANG Zhi-hua, XU Wen-yu. Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly[J]. Journal of Pharmaceutical Practice and Service, 2004, (2): 106-107.
Citation:
LAO Guo-qin, TANG Zhi-hua, XU Wen-yu. Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly[J]. Journal of Pharmaceutical Practice and Service, 2004, (2): 106-107.
Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly
Shaoxing Sixth People's Hospital, Shaoxing 312000, China
2.
Department of pharmacy, Shaoxing People's Hospital, Shaoxing 312000, China
Received Date: 2003-08-29
Abstract
Objective To evaluate the economic effectiveness of 3 therapeutic schemes for lower respiratory tract infection in the elderly. Methods Three schemes of the treatment of lower respiratory tract infection in the elderly from literatrure cefoperazone/sulbactam(A), imipenem/cilastatin(B), ceftazidime(C) were selected. Data was evaluated using the pharmacoeconomic cost-effectiveness analysis. Results According to the evaluation by cost-effectiveness analysis, C was the best scheme. Conclusion The cost-effectiveness analysis is very important in optimizing therapeutic scheme, guiding rational drug use and increasing economic effectiveness.
Abstract: Objective To evaluate the economic effectiveness of 3 therapeutic schemes for lower respiratory tract infection in the elderly. Methods Three schemes of the treatment of lower respiratory tract infection in the elderly from literatrure cefoperazone/sulbactam(A), imipenem/cilastatin(B), ceftazidime(C) were selected. Data was evaluated using the pharmacoeconomic cost-effectiveness analysis. Results According to the evaluation by cost-effectiveness analysis, C was the best scheme. Conclusion The cost-effectiveness analysis is very important in optimizing therapeutic scheme, guiding rational drug use and increasing economic effectiveness.
LAO Guo-qin, TANG Zhi-hua, XU Wen-yu. Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly[J]. Journal of Pharmaceutical Practice and Service, 2004, (2): 106-107.
Citation:
LAO Guo-qin, TANG Zhi-hua, XU Wen-yu. Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly[J]. Journal of Pharmaceutical Practice and Service, 2004, (2): 106-107.